234 related articles for article (PubMed ID: 35499412)
1. Cutaneous perivascular epithelioid cell tumor (PEComa): case report and world literature review of clinical and molecular characteristics.
Cohen PR; Kato SM; Erickson CP; Calame A; Kurzrock R
Dermatol Online J; 2022 Jan; 28(1):. PubMed ID: 35499412
[TBL] [Abstract][Full Text] [Related]
2. A rare metastatic mesenteric malignant PEComa with TSC2 mutation treated with palliative surgical resection and nab-sirolimus: a case report.
Meredith L; Chao T; Nevler A; Basu Mallick A; Singla RK; McCue PA; Bowne WB; Jiang W
Diagn Pathol; 2023 Apr; 18(1):45. PubMed ID: 37041531
[TBL] [Abstract][Full Text] [Related]
3. Primary cutaneous malignant perivascular epithelioid cell tumor: Case of a rare tumor with review of the literature.
Cole DW; Menge TD; Renati S; Bresler SC; Patel RM; Fullen DR; Hamp LM
J Cutan Pathol; 2021 Aug; 48(8):1088-1093. PubMed ID: 33908075
[TBL] [Abstract][Full Text] [Related]
4. PNL2: A Useful Adjunct Biomarker to HMB45 in the Diagnosis of Uterine Perivascular Epithelioid Cell Tumor (PEComa).
Valencia-Guerrero A; Pinto A; Anderson WJ; Trevisan G; Nucci MR; Hirsch MS
Int J Gynecol Pathol; 2020 Nov; 39(6):529-536. PubMed ID: 31851063
[TBL] [Abstract][Full Text] [Related]
5. TFE3-associated perivascular epithelioid cell tumor with complete response to mTOR inhibitor therapy: report of first case and literature review.
Purwar R; Soni K; Shukla M; Verma A; Kumar T; Pandey M
World J Surg Oncol; 2022 Mar; 20(1):62. PubMed ID: 35232443
[TBL] [Abstract][Full Text] [Related]
6. [Perivascular epithelioid cell tumor of urinary system: a clinicopathologic analysis of 21 cases].
Wang GW; Wang Y; Chen YX; Li Q; Shen DH
Zhonghua Bing Li Xue Za Zhi; 2012 Jul; 41(7):443-7. PubMed ID: 22932453
[TBL] [Abstract][Full Text] [Related]
7. A rare case of primary cutaneous malignant perivascular epithelioid cell tumor and review of the literature.
Cornell G; Jiang B; Ghaferi J
J Cutan Pathol; 2023 Apr; 50(4):301-305. PubMed ID: 36106729
[TBL] [Abstract][Full Text] [Related]
8. Perivascular epithelioid cell neoplasm (PEComa) of the gynecologic tract: clinicopathologic and immunohistochemical characterization of 16 cases.
Schoolmeester JK; Howitt BE; Hirsch MS; Dal Cin P; Quade BJ; Nucci MR
Am J Surg Pathol; 2014 Feb; 38(2):176-88. PubMed ID: 24418852
[TBL] [Abstract][Full Text] [Related]
9. Primary Cutaneous Malignant Perivascular Epithelioïd Cell Tumor (PEComa): Case Report With Review of the Literature.
Elousrouti LT; Mouaddine A; Fadlallah I; Elhitmy S; Elloudi S; Mernissi F; Elidrissi M; Hammas N; Elfatemi H; Chbani L
Clin Pathol; 2023; 16():2632010X231178629. PubMed ID: 37360521
[TBL] [Abstract][Full Text] [Related]
10. Malignant perivascular epithelioid cell neoplasm (PEComa) of the urinary bladder with TFE3 gene rearrangement: clinicopathologic, immunohistochemical, and molecular features.
Williamson SR; Bunde PJ; Montironi R; Lopez-Beltran A; Zhang S; Wang M; Maclennan GT; Cheng L
Am J Surg Pathol; 2013 Oct; 37(10):1619-26. PubMed ID: 23797724
[TBL] [Abstract][Full Text] [Related]
11. Clinical activity of mTOR inhibition with sirolimus in malignant perivascular epithelioid cell tumors: targeting the pathogenic activation of mTORC1 in tumors.
Wagner AJ; Malinowska-Kolodziej I; Morgan JA; Qin W; Fletcher CD; Vena N; Ligon AH; Antonescu CR; Ramaiya NH; Demetri GD; Kwiatkowski DJ; Maki RG
J Clin Oncol; 2010 Feb; 28(5):835-40. PubMed ID: 20048174
[TBL] [Abstract][Full Text] [Related]
12. [Uterine malignant perivascular epithelioid cell tumor (PEComa): Two case reports].
El Gani-Mesrar M; Bonneau C; Michenet P; Gourvennec JB; Tabareau-Delalande F
Ann Pathol; 2021 Feb; 41(1):118-122. PubMed ID: 32646778
[TBL] [Abstract][Full Text] [Related]
13. [A case of primary cutaneous PEComa].
Trotot-Voilliot C; Laveine E; Beurey P; Cuny JF; Schmutz JL; Truchetet F
Ann Dermatol Venereol; 2013 May; 140(5):373-7. PubMed ID: 23663710
[TBL] [Abstract][Full Text] [Related]
14. TFE3 Gene Rearrangement in Perivascular Epithelioid Cell Neoplasm (PEComa) of the Genitourinary Tract.
Vannucchi M; Minervini A; Salvi M; Montironi R; Raspollini MR
Clin Genitourin Cancer; 2020 Dec; 18(6):e692-e697. PubMed ID: 32576448
[TBL] [Abstract][Full Text] [Related]
15. [Perivascular epithelioid cell tumor, not otherwise specified: a clinicopathologic and immunohistochemical analysis of 31 cases].
Cai JN; Shi M; Wang J
Zhonghua Bing Li Xue Za Zhi; 2011 Apr; 40(4):240-5. PubMed ID: 21615997
[TBL] [Abstract][Full Text] [Related]
16. Extrarenal perivascular epithelioid cell tumors (PEComas) respond to mTOR inhibition: clinical and molecular correlates.
Dickson MA; Schwartz GK; Antonescu CR; Kwiatkowski DJ; Malinowska IA
Int J Cancer; 2013 Apr; 132(7):1711-7. PubMed ID: 22927055
[TBL] [Abstract][Full Text] [Related]
17. PEComa: morphology and genetics of a complex tumor family.
Thway K; Fisher C
Ann Diagn Pathol; 2015 Oct; 19(5):359-68. PubMed ID: 26144278
[TBL] [Abstract][Full Text] [Related]
18. Malignant Perivascular Epithelioid Cell Tumor (PEComa) of the Uterus as Part of the Hereditary Cancer Syndrome: A Case Diagnosed with Multiple Malignancies.
Caliskan S; Akar OS; Gun S; Kefeli M
Turk Patoloji Derg; 2023; 39(3):212-217. PubMed ID: 36367123
[TBL] [Abstract][Full Text] [Related]
19. Cutaneous "fibroma-like" perivascular epithelioid cell tumor: A case report and review of literature.
Odoño EIG; Tan KB; Tay SY; Lee VKM
J Cutan Pathol; 2020 Jun; 47(6):548-553. PubMed ID: 31943330
[TBL] [Abstract][Full Text] [Related]
20. Perivascular epithelioid cell tumor ('PEComa') of the uterus: a subset of HMB-45-positive epithelioid mesenchymal neoplasms with an uncertain relationship to pure smooth muscle tumors.
Vang R; Kempson RL
Am J Surg Pathol; 2002 Jan; 26(1):1-13. PubMed ID: 11756764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
